Literature DB >> 11090018

Severe necrotizing mastopathy caused by calciphylaxis alleviated by total parathyroidectomy.

P Patetsios1, M Bernstein, S Kim, R Mushnick, A Alfonso.   

Abstract

Calciphylaxis is a complication caused by secondary hyperparathyroidism in patients with chronic renal failure. These patients may present with clinical findings of ischemic necrosis involving the skin and muscle resulting in subsequent gangrene and vascular calcifications. We report a rare case of necrotizing mastopathy caused by calciphylaxis in a 70-year-old female with end-stage renal disease whose symptoms resolved with a total parathyroidectomy.

Entities:  

Mesh:

Year:  2000        PMID: 11090018

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

1.  Secondary hyperparathyroidism: Uncommon cause of a leg ulcer.

Authors:  L B van Rijssen; E E A Brenninkmeijer; E J M Nieveen van Dijkum
Journal:  Int J Surg Case Rep       Date:  2011-10-28

2.  Breast necrosis: calciphylaxis a rare cause.

Authors:  Joseph J Thornton; James Dolph
Journal:  Can J Plast Surg       Date:  2008

3.  Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism.

Authors:  Susumu Matsuoka; Susumu Matstusoka; Yoshihiro Tominaga; Nobuaki Uno; Norihiko Goto; Tetsuhiko Sato; Akio Katayama; Toshihito Haba; Kazuharu Uchida; Keiko Kobayashi; Akimasa Nakao
Journal:  World J Surg       Date:  2005-05       Impact factor: 3.352

Review 4.  Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

5.  Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kitravee Kongnatthasate; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.